# Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

> **NCT07293325** · NA · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 66 (estimated)

## Conditions studied

- Adults With Simple Obesity

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Tirzepatide
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT07293325
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2027-04-02
- **Final completion:** 2027-06-02
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07293325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07293325, "Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT07293325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*